|
|
Other links at Articles > Hematology-Oncology |
| 3. |
Rituximab Maintenance Halves Lymphoma Relapse
|
|
|
New results from the PRIMA study show benefits from rituximab maintenance therapy in patients who had responded to rituximab plus chemotherapy for induction. Medscape Medical News
|
| 4. |
Customizing Treatment for Advanced NSCLC: Histology Matters
|
|
|
Recent studies have found that specific histologic subgroups of NSCLC respond more favorably to particular therapies. This expert column focuses on the role of histology in selecting NSCLC therapies and improving patient outcomes. Medscape Hematology-Oncology
|
|
|